SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338795
Filing Date
2017-11-09
Accepted
2017-11-09 16:17:25
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d440991d10q.htm 10-Q 372202
2 EX-31.1 d440991dex311.htm EX-31.1 6882
3 EX-31.2 d440991dex312.htm EX-31.2 6991
4 EX-32.1 d440991dex321.htm EX-32.1 4577
  Complete submission text file 0001193125-17-338795.txt   3511202

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zsan-20170930.xml EX-101.INS 667211
6 XBRL TAXONOMY EXTENSION SCHEMA zsan-20170930.xsd EX-101.SCH 44680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20170930_cal.xml EX-101.CAL 58144
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20170930_def.xml EX-101.DEF 181595
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20170930_lab.xml EX-101.LAB 391906
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20170930_pre.xml EX-101.PRE 266035
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 171191070
SIC: 2834 Pharmaceutical Preparations